Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
about
Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach.Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trialCruciferous vegetables, isothiocyanates, and prevention of bladder cancer.Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway.Thermodynamics as the driving principle behind the immune system.
P2860
Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@en
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@nl
type
label
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@en
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@nl
prefLabel
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@en
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@nl
P2093
P2860
P356
P1476
Efficacy of combined intravesi ...... uscle invasive bladder cancer.
@en
P2093
Barbara Ercole
Dipen J Parekh
Guru Sonpavde
Rita Ghosh
Robert S Svatek
William M Hilton
P2860
P304
P356
10.1586/ERA.11.69
P577
2011-06-01T00:00:00Z